Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation.

Thrombospondins: A Role in Cardiovascular Disease. Int J Mol Sci (2017) 0.75

NIH Image to ImageJ: 25 years of image analysis. Nat Methods (2012) 84.41

Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63

The Reactome pathway knowledgebase. Nucleic Acids Res (2013) 8.56

Autocrine VEGF signaling is required for vascular homeostasis. Cell (2007) 7.37

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A (1990) 5.26

Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature (1993) 5.23

A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol (2008) 5.11

Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development (1992) 4.69

Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature (2008) 3.67

Rule-based modeling of biochemical systems with BioNetGen. Methods Mol Biol (2009) 3.47

Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J (2003) 2.93

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol (1990) 2.69

The role of vascular endothelial growth factor in wound healing. J Surg Res (2008) 2.68

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med (2011) 2.38

Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers (Basel) (2012) 2.35

CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem (2006) 2.23

Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output. Blood (2011) 2.12

Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res (2006) 2.08

Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med (2012) 1.99

Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer (2009) 1.95

Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol (1993) 1.92

Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc Res (2010) 1.91

Endogenous angiogenesis inhibitors. APMIS (2004) 1.89

Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol Cell Biol (2002) 1.85

Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic (2006) 1.78

Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J Biol Chem (2001) 1.71

Vascular endothelial growth factor a in intraocular vascular disease. Ophthalmology (2012) 1.63

Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun (1990) 1.62

The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem (2000) 1.60

Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation. Circ Res (2011) 1.47

Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem (2001) 1.44

Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem (2007) 1.41

Therapeutic angiogenesis for critical limb ischaemia. Nat Rev Cardiol (2013) 1.38

Ligand-stimulated VEGFR2 signaling is regulated by co-ordinated trafficking and proteolysis. Traffic (2010) 1.36

Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol (2007) 1.35

Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis (1999) 1.31

Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem (2010) 1.27

Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer. J Biol Chem (2005) 1.24

Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg (2008) 1.24

Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. J Cell Physiol (1991) 1.23

Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1. J Biol Chem (2009) 1.16

A mathematical model of plasma membrane electrophysiology and calcium dynamics in vascular endothelial cells. Am J Physiol Cell Physiol (2007) 1.15

New role for the protein tyrosine phosphatase DEP-1 in Akt activation and endothelial cell survival. Mol Cell Biol (2008) 1.13

Phosphorylation of Akt and ERK1/2 is required for VEGF-A/VEGFR2-induced proliferation and migration of lymphatic endothelium. PLoS One (2011) 1.06

Essential role of calcium in vascular endothelial growth factor A-induced signaling: mechanism of the antiangiogenic effect of carboxyamidotriazole. FASEB J (2002) 1.05

Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov (2016) 1.03

Angiogenesis in embryonic development--a review. Placenta (2000) 0.96

Vascular endothelial growth factor and vascular homeostasis. Proc Am Thorac Soc (2011) 0.93

Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy. Clin Cancer Res (2008) 0.93

Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition. PLoS One (2012) 0.92

The complexity of cell signaling and the need for a new mechanics. Sci Signal (2009) 0.92

CD47 signaling regulates the immunosuppressive activity of VEGF in T cells. J Immunol (2014) 0.87

Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury. J Am Soc Nephrol (2014) 0.84

VEGFR2 trafficking: speed doesn't kill. Cell Cycle (2013) 0.83

Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice. Matrix Biol (2014) 0.83

A mathematical model of T lymphocyte calcium dynamics derived from single transmembrane protein properties. Front Immunol (2013) 0.82

Targeting receptor tyrosine kinases and their downstream signaling with cell-penetrating peptides in human pulmonary artery smooth muscle and endothelial cells. Chem Biol Drug Des (2014) 0.79

Anti-VEGF Therapy and the Retina: An Update. J Ophthalmol (2015) 0.78

Molecular mechanism matters: Benefits of mechanistic computational models for drug development. Pharmacol Res (2015) 0.77

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells. Oncogene (2015) 0.76

Computational drug repositioning for peripheral arterial disease: prediction of anti-inflammatory and pro-angiogenic therapeutics. Front Pharmacol (2015) 0.76

Corrigendum: Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): In silico Investigation. Front Physiol (2017) 0.75